Quadrant Capital Group LLC Heska Corp Transaction History

Quadrant Capital Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$62.17 - $97.62 $17,096 - $26,845	275 Added 90.16%	580 $56,000
Q4 2022 Feb 10, 2023	BUY	$60.21 - $77.74 $2,528 - $3,265	42 Added 15.97%	305 $18,000
Q3 2022 Nov 10, 2022	BUY	$72.92 - $99.73 $11,885 - $16,255	163 Added 163.0%	263 $19,000
Q2 2022 Aug 09, 2022	BUY	$84.23 - $147.57 $8,086 - $14,166	96 Added 2400.0%	100 $9,000
Q1 2022 May 06, 2022	BUY	$122.89 - $171.74 $491 - $686	4 New	4 $1,000
Q3 2020 Nov 13, 2020	SELL	$90.16 - $107.61 $51,391 - $61,337	-570 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$52.17 - $95.63 $29,736 - $54,509	570 New	570 $53,000
Q4 2017 Jan 31, 2018	SELL	$77.49 - $98.41 $3,564 - $4,526	-46 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	46	46 $4,000

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.